Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

Niklas Worm Andersson; Emilia Myrup Thiesson; Ulrike Baum; Nicklas Pihlstrom; Jostein Starrfelt; Kristyna Faksova; Eero Poukka; Lars Christian Lund; Christian Holm Hansen; Mia Aakjaer; Jesper Kjaer; Catherine Cohet; Mathijs Goossens; Morten Andersen; Jesper Hallas; Hinta Meijerink; Rickard Ljung; Anders Hviid

doi:10.1136/bmj-2022-074325

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

Niklas Worm Andersson, Emilia Myrup Thiesson, Ulrike Baum, Nicklas Pihlstrom, Jostein Starrfelt, Kristyna Faksova, Eero Poukka, Lars Christian Lund, Christian Holm Hansen, Mia Aakjaer, Jesper Kjaer, Catherine Cohet, Mathijs Goossens, Morten Andersen, Jesper Hallas, Hinta Meijerink, Rickard Ljung, Anders Hviid

Department of Public Health

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	e074325
Journal	BMJ : British Medical Journal
Volume	382
Number of pages	15
ISSN	0959-535X
DOIs	https://doi.org/10.1136/bmj-2022-074325
Publication status	Published - 24 Jul 2023
MoE publication type	A1 Journal article-refereed

Fields of Science

3142 Public health care science, environmental and occupational health

Access to Document

10.1136/bmj-2022-074325

bmj-2022-074325.fullFinal published version, 962 KBLicence: CC BY-NC

Cite this

Andersson, N. W., Thiesson, E. M., Baum, U., Pihlstrom, N., Starrfelt, J., Faksova, K., Poukka, E., Lund, L. C., Hansen, C. H., Aakjaer, M., Kjaer, J., Cohet, C., Goossens, M., Andersen, M., Hallas, J., Meijerink, H., Ljung, R., & Hviid, A. (2023). Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses. BMJ : British Medical Journal, 382, Article e074325. https://doi.org/10.1136/bmj-2022-074325

@article{d408d6cf2b7c4394b52844291ec3c90c,

title = "Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses",

keywords = "Immunogenicity, Bnt162b2, Phase-2, Safety, 3142 Public health care science, environmental and occupational health",

author = "Andersson, \{Niklas Worm\} and Thiesson, \{Emilia Myrup\} and Ulrike Baum and Nicklas Pihlstrom and Jostein Starrfelt and Kristyna Faksova and Eero Poukka and Lund, \{Lars Christian\} and Hansen, \{Christian Holm\} and Mia Aakjaer and Jesper Kjaer and Catherine Cohet and Mathijs Goossens and Morten Andersen and Jesper Hallas and Hinta Meijerink and Rickard Ljung and Anders Hviid",

year = "2023",

month = jul,

day = "24",

doi = "10.1136/bmj-2022-074325",

language = "English",

volume = "382",

journal = "BMJ : British Medical Journal",

issn = "0959-535X",

publisher = "BMJ Publishing Group Ltd",

}

Andersson, NW, Thiesson, EM, Baum, U, Pihlstrom, N, Starrfelt, J, Faksova, K, Poukka, E, Lund, LC, Hansen, CH, Aakjaer, M, Kjaer, J, Cohet, C, Goossens, M, Andersen, M, Hallas, J, Meijerink, H, Ljung, R & Hviid, A 2023, 'Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses', BMJ : British Medical Journal, vol. 382, e074325. https://doi.org/10.1136/bmj-2022-074325

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses. / Andersson, Niklas Worm; Thiesson, Emilia Myrup; Baum, Ulrike et al.
In: BMJ : British Medical Journal, Vol. 382, e074325, 24.07.2023.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries

T2 - population based cohort analyses

AU - Andersson, Niklas Worm

AU - Thiesson, Emilia Myrup

AU - Baum, Ulrike

AU - Pihlstrom, Nicklas

AU - Starrfelt, Jostein

AU - Faksova, Kristyna

AU - Poukka, Eero

AU - Lund, Lars Christian

AU - Hansen, Christian Holm

AU - Aakjaer, Mia

AU - Kjaer, Jesper

AU - Cohet, Catherine

AU - Goossens, Mathijs

AU - Andersen, Morten

AU - Hallas, Jesper

AU - Meijerink, Hinta

AU - Ljung, Rickard

AU - Hviid, Anders

PY - 2023/7/24

Y1 - 2023/7/24

KW - Immunogenicity

KW - Bnt162b2

KW - Phase-2

KW - Safety

KW - 3142 Public health care science, environmental and occupational health

U2 - 10.1136/bmj-2022-074325

DO - 10.1136/bmj-2022-074325

M3 - Article

C2 - 37487623

SN - 0959-535X

VL - 382

JO - BMJ : British Medical Journal

JF - BMJ : British Medical Journal

M1 - e074325

ER -